Gallstones Associated with Nonalcoholic Steatohepatitis (NASH) and Metabolic Syndrome
Overview
Affiliations
Background/aims: We aimed to evaluate the prevalence of non-alcoholic steatohepatitis and metabolic syndrome in patients with symptomatic gallstones undergoing laparoscopic or open cholecystectomy.
Methods: A study of 95 patients was performed. Simultaneous liver biopsies were taken during cholecystectomy between 2006 and 2007. There were no postoperative complications. Patients with significant alcohol intake, hepatitis B or C (virus-positive), autoimmune diseases, and Wilson's disease were excluded. Demographics, liver function tests, lipid profile, and ultrasound findings of patients with and without non-alcoholic steatohepatitis were compared.
Results: A total of 95 patients completed the study. The mean age was 52.15 years, and 29 patients were male and 66 female. Fifty-two patients (55%) had biopsies compatible with non-alcoholic steatohepatitis.
Conclusions: Fifty-five percent of patients with gallbladder stones had associated non-alcoholic steatohepatitis. Awareness of this association may result in an earlier diagnosis. The high prevalence of non-alcoholic steatohepatitis in patients with gallbladder stone may justify routine liver biopsy during cholecystectomy to establish the diagnosis and stage and possibly direct therapy.
John A, Anand U, Kumar T, Kodali R, Parasar K, Kumar R Turk J Surg. 2025; 40(3):190-196.
PMID: 39917405 PMC: 11792899. DOI: 10.47717/turkjsurg.2024.6488.
Macias J, Parra-Membrives P, Sosa-Moreno F, Rincon P, Martinez-Baena D, Fernandez-Fuertes M Sci Rep. 2022; 12(1):21897.
PMID: 36536019 PMC: 9763491. DOI: 10.1038/s41598-022-25931-7.
Sepehrimanesh M, Niknam R, Ejtehadi F, Fattahi M, Safarpour A Diabetes Metab Syndr Obes. 2020; 13:1449-1458.
PMID: 32431528 PMC: 7200259. DOI: 10.2147/DMSO.S246949.
Prevalence of biopsy-proven nonalcoholic fatty liver among patients with gallstone disease.
Alsaif F, AlQahtani S, Alsadoon A, Alswat K, Abdo A, Hassanain M Saudi J Gastroenterol. 2020; .
PMID: 32341228 PMC: 7580734. DOI: 10.4103/sjg.SJG_29_20.
Cholecystectomy does not worsen progression or outcomes in non-alcoholic fatty liver disease.
Kakati D, Kumar U, Russ K, Shoreibah M, Kuo Y, Jackson B Transl Gastroenterol Hepatol. 2020; 5:3.
PMID: 32190771 PMC: 7061184. DOI: 10.21037/tgh.2019.09.03.